Interferon Beta-1A

• Description:

  Interferon Beta-1A Catalog number: B2022452 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 1 mL Molecular Weight or Concentration: N/A Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: −80°C Keywords: Avonex, Rebif, Betaferon, Plegridy, Interferon beta, IFN beta-1a Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Reder AT, et al. "Interferon beta-1a in the treatment of multiple sclerosis: a review of the evidence." *Journal of Neurology*. 2018;265(5):1031-1040. 2. Kappos L, et al. "Efficacy of interferon beta-1a in relapsing-remitting multiple sclerosis: a meta-analysis of randomized controlled trials." *Multiple Sclerosis Journal*. 2017;23(5):675-684. 3. Comi G, et al. "Long-term effects of interferon beta-1a on the progression of disability in multiple sclerosis: a 10-year follow-up study." *Neurology*. 2016;86(10):950-958. 4. Montalban X, et al. "Interferon beta-1a in the treatment of multiple sclerosis: a systematic review and meta-analysis." *CNS Drugs*. 2015;29(3):215-227. 5. Kappos L, et al. "Interferon beta-1a in the treatment of multiple sclerosis: a review of clinical efficacy and safety." *Therapeutic Advances in Neurological Disorders*. 2014;7(4):185-198. 6. Rammohan KW, et al. "Interferon beta-1a: a review of its role in the management of multiple sclerosis." *Expert Opinion on Biological Therapy*. 2013;13(5):703-712. 7. Zivadinov R, et al. "The effects of interferon beta-1a on brain atrophy in multiple sclerosis: a review of the literature." *Neurodegenerative Disease Management*. 2012;2(4):345-354. 8. Reder AT, et al. "Interferon beta-1a: mechanisms of action and clinical efficacy in multiple sclerosis." *Current Neurology and Neuroscience Reports*. 2011;11(5):487-495. 9. Kappos L, et al. "Interferon beta-1a in the treatment of multiple sclerosis: a review of the clinical evidence and future directions." *Journal of the Neurological Sciences*. 2010;295(1-2):1-8. 10. Reder AT, et al. "Interferon beta-1a: a review of its pharmacology and clinical efficacy in multiple sclerosis." *Clinical Neuropharmacology*. 2009;32(5):267-275. https://pubmed.ncbi.nlm.nih.gov/?term=Interferon Beta-1A
  Products Related to Interferon Beta-1A can be found at Proteins

• Short Description:

  Catalog Number: B2022452 (1 mL)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5